title: Reply from Authors re: Andrew J. Vickers, Michael J. Pencina. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol 2013;64:394-6: prostate-specific antigen velocity: new unscreened cohort, natural history of prostate cancer, room for different interpretations.
authors.affiliation: Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
authors.forename: David D
authors.initials: DD
authors.lastname: Ørsted
authors.forename: Stig E
authors.initials: SE
authors.lastname: Bojesen
authors.forename: Pia R
authors.initials: PR
authors.lastname: Kamstrup
authors.forename: Børge G
authors.initials: BG
authors.lastname: Nordestgaard
mesh_terms: D006801:Humans; D007610:Kallikreins / Q000378:metabolism*; D008297:Male; D017430:Prostate-Specific Antigen / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000401:mortality*
chemical_list: C549870:KLK3 protein, human; D007610:Kallikreins; D017430:Prostate-Specific Antigen